June 10, 2015
LA JOLLA, CA–The Salk Institute is pleased to announce the election of neuroscientist Thomas M. Jessell and business leader Daniel Tierney to its Board of Trustees. The Board voted on the appointments in April.
“I am pleased to welcome Tom and Dan to the Salk Board of Trustees,” said Board Chairman Irwin Jacobs. “Tom’s understanding of the Salk’s mission and the importance of basic research, and Dan’s outstanding record of entrepreneurial and business success, will help guide the Institute as we undertake new and important priorities.”
Dr. Jessell has been a Salk Institute Non-Resident Fellow since 2001. He is the recipient of the Kavli Prize in Neuroscience, a member of the Royal Society, a member of the National Academy of Sciences, and holds many other distinctions and honors. He is the Claire Tow Professor in the Department of Neuroscience and the Department of Biochemistry and Molecular Biophysics at Columbia University. His research explores the link between the assembly and organization of neural networks and the behaviors they encode.
Mr. Tierney is the cofounder of GETCO (now KCG), one of the world’s leading technology-enabled market makers and agency execution service providers. He currently serves as a board member and advisor at KCG. After stepping down from the co-CEO role at GETCO in 2012, Mr. Tierney became the founder and president of Wicklow Capital. Prior to founding GETCO, Mr. Tierney worked as a market maker on the floor of the Chicago Board Options Exchange. He holds a degree in Economics and Finance from Bentley College in Massachusetts.
About the Salk Institute for Biological Studies:
The Salk Institute for Biological Studies is one of the world’s preeminent basic research institutions, where internationally renowned faculty probes fundamental life science questions in a unique, collaborative and creative environment. Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer’s, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology, and related disciplines.
Faculty achievements have been recognized with numerous honors, including Nobel Prizes and memberships in the National Academy of Sciences. Founded in 1960 by polio vaccine pioneer Jonas Salk, MD, the Institute is an independent nonprofit organization and architectural landmark.
Office of Communications
Tel: (858) 453-4100
press@salk.edu
Your partnership allows our scientists to accelerate the pace of high-risk, high-reward discoveries that have the potential to benefit the health of all humanity-be it cancer, Alzheimer’s disease, climate change, infectious diseases or more.
